Skip to main content
Caplight Logo









Aetas Pharma Co., Ltd.

Aetas Pharma Co., Ltd.

Private
TokyoHealthcare & Life Scienceshttps://www.aetaspharma.com/

Company Overview

Aetas Pharma Co., Ltd. operates in Healthcare & Life Sciences and is based in Tokyo. It was founded in 2000.

Aetas Pharma Co., Ltd. is a biotechnology company that researches and develops novel therapeutic agents for heart and kidney diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Aetas Pharma Co., Ltd. Comparables

Compare Aetas Pharma Co., Ltd. with similar companies based on industry and business-model similarity.

Aetas Pharma Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SCOHIA PHARMA, Inc.
81%
NovaRhythm Biosciences
78%
Cardurion Pharmaceuticals
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Aetas Pharma Co., Ltd. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Aetas Pharma Co., Ltd.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 6, 2025

    Monthly visitors increased 52% MoM.

  • May 1, 2025

    Monthly visitors increased 83% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Aetas Pharma Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Aetas Pharma Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Aetas Pharma Co., Ltd.'s valuation, stock price, and market status.

Is Aetas Pharma Co., Ltd. a public or private company?

Aetas Pharma Co., Ltd. is a private company.

What is the current stock price of Aetas Pharma Co., Ltd.?

Aetas Pharma Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Aetas Pharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Aetas Pharma Co., Ltd. worth (valuation)?

Valuation information for Aetas Pharma Co., Ltd. is not publicly available.

Can I buy Aetas Pharma Co., Ltd. stock?

Aetas Pharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Aetas Pharma Co., Ltd.'s last funding round?

Funding round information for Aetas Pharma Co., Ltd. is not publicly available.

Who are the main investors in Aetas Pharma Co., Ltd.?

Investor information for Aetas Pharma Co., Ltd. is not publicly disclosed.

Will Aetas Pharma Co., Ltd. IPO soon?

No public IPO plans have been announced for Aetas Pharma Co., Ltd..

How can I track Aetas Pharma Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Aetas Pharma Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersTokyo
Year Founded2000
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?